The forecast for the sold production of basic pharmaceutical products in Poland shows a declining trend from 2024 to 2028. In 2023, the actual production stood significantly higher than the forecasted figures, which are expected to decrease from 6.8422 million euros in 2024 to 5.8718 million euros in 2028. The year-on-year variation percentage illustrates a consistent decrease each year: -3.7% from 2024 to 2025, -3.7% from 2025 to 2026, -3.8% from 2026 to 2027, and -3.9% from 2027 to 2028. The compound annual growth rate (CAGR) over the five-year period from 2024 to 2028 is also negative, indicating an average annual decrease in production.
Future Trends to Watch For:
- Regulatory changes that could impact production capabilities or costs
- Technological advancements in pharmaceutical manufacturing
- Shifts in global pharmaceutical demand and supply chains
- Innovations in drug development and emerging biotech sectors
- Economic factors affecting healthcare budgets and expending in Poland
Latest reports
US Erectile Dysfunction Market Report- Q1 2025
The US Erectile Dysfunction (ED) market in Q1 2025 is navigating a challenging economic landscape marked by inflationary pressures, geopolitical tensions, and a...
South Korea Erectile Dysfunction Market Report- Q4 2024
The South Korean Erectile Dysfunction (ED) market in the fourth quarter of 2024 is characterized by evolving consumer preferences, technological innovations, and economic...
Spain Erectile Dysfunction Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic period for the Erectile Dysfunction (ED) market in Spain, marked by significant developments and emerging...
